Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
Status:
Active, not recruiting
Trial end date:
2021-09-09
Target enrollment:
Participant gender:
Summary
This study is designed to assess whether consumers select and use norgestrel 0.075 mg, a
progestin only pill for contraception, in a manner consistent with the OTC package directions
in an Over-the-Counter (OTC)-like setting.